Update from the Food and Drug Agency comes days after Philips said it would stop selling the devices in the U.S.
The Food and Drug Administration says 561 deaths have been reported in connection to recalled Philips devices to treat obstructive sleep apnea and other breathing disorders.The FDA said that since April 2021 it has received more than 116,000 medical device reports of foam breaking down in Philips CPAP machines and BiPAP sleep therapy devices. That includes 561 reports of death, the agency said Wednesday.
Claims for financial losses related to the purchase, lease or rent of the recalled devices can be made, with eligible users entitled to:a Device Payment Award for each recalled device purchased, leased or rented;a Device Return Award of $100 for each recalled device returned by Aug. 9, 2024; and/ora Device Replacement Award for money spent to buy a comparable machine on or after June 14, 2021 and before Sept. 7, 2023 to replace a recalled device.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Update: SM Entertainment Shares Update On SHINee’s ContractsUpdate: SM Entertainment Shares Update On SHINee’s Contracts
Read more »
Dior Beauty and Peter Philips Celebrate the Launch of Rouge Dior in Beverly HillsThe Creative and Image Director and friends of the house celebrate the revival of the beloved lipstick
Read more »
The Morning After: Samsung gets FDA approval for its sleep apnea feature on Galaxy WatchMat Smith heads up Engadget’s daily newsletter from London, UK. He has worked at Engadget for over a decade and has covered console gaming, flagship smartphones, the Apple Watch and fitness tech that promises to make him faster or stronger. He’s currently learning how to backflip.
Read more »
Vaccines Protect You & Your Kids From Measles: FDAAs new outbreaks of measles -- a once nearly eliminated illness in the United States -- continue to emerge, experts remind Americans that there's an easy way to stop infection: Get vaccinated.
Read more »
FDA Approves First OTC Continuous Glucose MonitorThe Dexcom Stelo Glucose Biosensor System is for adults with or without diabetes who don't use insulin.
Read more »
Yogurt Makers Can Make Limited Claims About Type 2 Diabetes Prevention: FDAYogurt makers can now make limited claims about the food's power to help prevent type 2 diabetes, the U.S. Food and Drug Administration says.
Read more »